ArticleJournal of arrhythmia2021

Safety and effectiveness of edoxaban in Japanese patients with nonvalvular atrial fibrillation: Final report of a two-year postmarketing surveillance study (ETNA-AF-Japan).

Takeshi Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.